Finance News – Sarepta Therapeutics
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Sarepta Therapeutics Stock Surges as FDA Allows Elevidys Sales to Resume
The approval to restart Elevidys sales has notably impacted Sarepta Therapeutics' market value, reflecting investor confidence and a positive shift in the company's financial outlo...
Read Full Article →Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments
The decision to stop shipments of the gene therapy in response to regulatory demands has led to a decline in shareholder confidence, impacting the company’s market valuation on Tue...
Read Full Article →Sarepta Therapeutics Stock Tumbles on Report of Third Death in Clinical Trial
The recent report of a fatality in the ongoing clinical study has adversely affected the company’s market valuation, reflecting investor concerns about potential risks and future f...
Read Full Article →Sarepta Therapeutics Stock Soars on Beleaguered Drugmaker's Restructuring Plan
The company’s recent organizational changes have led to increased investor confidence, resulting in a notable rise in its market valuation and trading activity.
Read Full Article →ROSEN, A LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before...
Investors in Sarepta Therapeutics, Inc. may face potential financial impact due to ongoing legal proceedings, prompting the importance of obtaining professional legal advice before...
Read Full Article →INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sa...
Investors in Sarepta Therapeutics are urged to consider potential legal actions, as upcoming deadlines may impact their ability to seek compensation related to recent financial dev...
Read Full Article →ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel B...
Investors in Sarepta Therapeutics, Inc. may face potential financial implications related to recent legal developments, prompting the importance of seeking professional advice prio...
Read Full Article →ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Cou...
Investors in Sarepta Therapeutics, Inc. may face potential financial risks related to ongoing legal proceedings, making it important to obtain legal advice before the approaching d...
Read Full Article →Sarepta Therapeutics Stock Plunges as Second Patient Dies Taking Its Drug
The company's shares experienced a sharp decline following reports of a fatality linked to its medication, raising concerns among investors about potential risks and regulatory imp...
Read Full Article →